Global Inherited Metabolic Disorder Supply, Demand and Key Producers, 2023-2029
The global Inherited Metabolic Disorder market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Inherited Metabolic Disorder demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Inherited Metabolic Disorder, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inherited Metabolic Disorder that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Inherited Metabolic Disorder total market, 2018-2029, (USD Million)
Global Inherited Metabolic Disorder total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Inherited Metabolic Disorder total market, key domestic companies and share, (USD Million)
Global Inherited Metabolic Disorder revenue by player and market share 2018-2023, (USD Million)
Global Inherited Metabolic Disorder total market by Type, CAGR, 2018-2029, (USD Million)
Global Inherited Metabolic Disorder total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Inherited Metabolic Disorder market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mayo Clinic, Angeion Corporation, Abbott U.S., Admera Health, Promega Corporation, Alomone Labs, Bio-Rad Laboratories, Novartis AG and AstaReal, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inherited Metabolic Disorder market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Inherited Metabolic Disorder Market, By Region:
1. How big is the global Inherited Metabolic Disorder market?
2. What is the demand of the global Inherited Metabolic Disorder market?
3. What is the year over year growth of the global Inherited Metabolic Disorder market?
4. What is the total value of the global Inherited Metabolic Disorder market?
5. Who are the major players in the global Inherited Metabolic Disorder market?
6. What are the growth factors driving the market demand?
This report studies the global Inherited Metabolic Disorder demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Inherited Metabolic Disorder, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Inherited Metabolic Disorder that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Inherited Metabolic Disorder total market, 2018-2029, (USD Million)
Global Inherited Metabolic Disorder total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Inherited Metabolic Disorder total market, key domestic companies and share, (USD Million)
Global Inherited Metabolic Disorder revenue by player and market share 2018-2023, (USD Million)
Global Inherited Metabolic Disorder total market by Type, CAGR, 2018-2029, (USD Million)
Global Inherited Metabolic Disorder total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Inherited Metabolic Disorder market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mayo Clinic, Angeion Corporation, Abbott U.S., Admera Health, Promega Corporation, Alomone Labs, Bio-Rad Laboratories, Novartis AG and AstaReal, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Inherited Metabolic Disorder market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Inherited Metabolic Disorder Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Enzyme Replacement Therapy
- Cellular Transplantation
- Small Molecule Based Therapy
- Substrate Reduction Therapy
- Gene Therapy
- Drug Therapy
- Others
- Hurler Syndrome
- Niemann-Pick Disease
- Tay-Sachs Disease
- Gaucher Disease
- Fabry Disease
- Krabbe Disease
- Others
- Mayo Clinic
- Angeion Corporation
- Abbott U.S.
- Admera Health
- Promega Corporation
- Alomone Labs
- Bio-Rad Laboratories
- Novartis AG
- AstaReal
- Regeneron Pharmaceuticals
- Biophytis
- AbbVie
- Danone
- Pfizer
- Bristol Myers Squibb
- Biogen
- GSK plc
- Roche Holding AG
1. How big is the global Inherited Metabolic Disorder market?
2. What is the demand of the global Inherited Metabolic Disorder market?
3. What is the year over year growth of the global Inherited Metabolic Disorder market?
4. What is the total value of the global Inherited Metabolic Disorder market?
5. Who are the major players in the global Inherited Metabolic Disorder market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Inherited Metabolic Disorder Introduction
1.2 World Inherited Metabolic Disorder Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Inherited Metabolic Disorder Total Market by Region (by Headquarter Location)
1.3.1 World Inherited Metabolic Disorder Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Inherited Metabolic Disorder Market Size (2018-2029)
1.3.3 China Inherited Metabolic Disorder Market Size (2018-2029)
1.3.4 Europe Inherited Metabolic Disorder Market Size (2018-2029)
1.3.5 Japan Inherited Metabolic Disorder Market Size (2018-2029)
1.3.6 South Korea Inherited Metabolic Disorder Market Size (2018-2029)
1.3.7 ASEAN Inherited Metabolic Disorder Market Size (2018-2029)
1.3.8 India Inherited Metabolic Disorder Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Inherited Metabolic Disorder Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Inherited Metabolic Disorder Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Inherited Metabolic Disorder Consumption Value (2018-2029)
2.2 World Inherited Metabolic Disorder Consumption Value by Region
2.2.1 World Inherited Metabolic Disorder Consumption Value by Region (2018-2023)
2.2.2 World Inherited Metabolic Disorder Consumption Value Forecast by Region (2024-2029)
2.3 United States Inherited Metabolic Disorder Consumption Value (2018-2029)
2.4 China Inherited Metabolic Disorder Consumption Value (2018-2029)
2.5 Europe Inherited Metabolic Disorder Consumption Value (2018-2029)
2.6 Japan Inherited Metabolic Disorder Consumption Value (2018-2029)
2.7 South Korea Inherited Metabolic Disorder Consumption Value (2018-2029)
2.8 ASEAN Inherited Metabolic Disorder Consumption Value (2018-2029)
2.9 India Inherited Metabolic Disorder Consumption Value (2018-2029)
3 WORLD INHERITED METABOLIC DISORDER COMPANIES COMPETITIVE ANALYSIS
3.1 World Inherited Metabolic Disorder Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Inherited Metabolic Disorder Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Inherited Metabolic Disorder in 2022
3.2.3 Global Concentration Ratios (CR8) for Inherited Metabolic Disorder in 2022
3.3 Inherited Metabolic Disorder Company Evaluation Quadrant
3.4 Inherited Metabolic Disorder Market: Overall Company Footprint Analysis
3.4.1 Inherited Metabolic Disorder Market: Region Footprint
3.4.2 Inherited Metabolic Disorder Market: Company Product Type Footprint
3.4.3 Inherited Metabolic Disorder Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Inherited Metabolic Disorder Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Inherited Metabolic Disorder Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Inherited Metabolic Disorder Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Inherited Metabolic Disorder Consumption Value Comparison
4.2.1 United States VS China: Inherited Metabolic Disorder Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Inherited Metabolic Disorder Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Inherited Metabolic Disorder Companies and Market Share, 2018-2023
4.3.1 United States Based Inherited Metabolic Disorder Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Inherited Metabolic Disorder Revenue, (2018-2023)
4.4 China Based Companies Inherited Metabolic Disorder Revenue and Market Share, 2018-2023
4.4.1 China Based Inherited Metabolic Disorder Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Inherited Metabolic Disorder Revenue, (2018-2023)
4.5 Rest of World Based Inherited Metabolic Disorder Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Inherited Metabolic Disorder Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Inherited Metabolic Disorder Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Inherited Metabolic Disorder Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Enzyme Replacement Therapy
5.2.2 Cellular Transplantation
5.2.3 Small Molecule Based Therapy
5.2.4 Substrate Reduction Therapy
5.2.5 Gene Therapy
5.2.6 Drug Therapy
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World Inherited Metabolic Disorder Market Size by Type (2018-2023)
5.3.2 World Inherited Metabolic Disorder Market Size by Type (2024-2029)
5.3.3 World Inherited Metabolic Disorder Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Inherited Metabolic Disorder Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hurler Syndrome
6.2.2 Niemann-Pick Disease
6.2.3 Tay-Sachs Disease
6.2.4 Gaucher Disease
6.2.5 Gaucher Disease
6.2.6 Krabbe Disease
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World Inherited Metabolic Disorder Market Size by Application (2018-2023)
6.3.2 World Inherited Metabolic Disorder Market Size by Application (2024-2029)
6.3.3 World Inherited Metabolic Disorder Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Mayo Clinic
7.1.1 Mayo Clinic Details
7.1.2 Mayo Clinic Major Business
7.1.3 Mayo Clinic Inherited Metabolic Disorder Product and Services
7.1.4 Mayo Clinic Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Mayo Clinic Recent Developments/Updates
7.1.6 Mayo Clinic Competitive Strengths & Weaknesses
7.2 Angeion Corporation
7.2.1 Angeion Corporation Details
7.2.2 Angeion Corporation Major Business
7.2.3 Angeion Corporation Inherited Metabolic Disorder Product and Services
7.2.4 Angeion Corporation Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Angeion Corporation Recent Developments/Updates
7.2.6 Angeion Corporation Competitive Strengths & Weaknesses
7.3 Abbott U.S.
7.3.1 Abbott U.S. Details
7.3.2 Abbott U.S. Major Business
7.3.3 Abbott U.S. Inherited Metabolic Disorder Product and Services
7.3.4 Abbott U.S. Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Abbott U.S. Recent Developments/Updates
7.3.6 Abbott U.S. Competitive Strengths & Weaknesses
7.4 Admera Health
7.4.1 Admera Health Details
7.4.2 Admera Health Major Business
7.4.3 Admera Health Inherited Metabolic Disorder Product and Services
7.4.4 Admera Health Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Admera Health Recent Developments/Updates
7.4.6 Admera Health Competitive Strengths & Weaknesses
7.5 Promega Corporation
7.5.1 Promega Corporation Details
7.5.2 Promega Corporation Major Business
7.5.3 Promega Corporation Inherited Metabolic Disorder Product and Services
7.5.4 Promega Corporation Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Promega Corporation Recent Developments/Updates
7.5.6 Promega Corporation Competitive Strengths & Weaknesses
7.6 Alomone Labs
7.6.1 Alomone Labs Details
7.6.2 Alomone Labs Major Business
7.6.3 Alomone Labs Inherited Metabolic Disorder Product and Services
7.6.4 Alomone Labs Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Alomone Labs Recent Developments/Updates
7.6.6 Alomone Labs Competitive Strengths & Weaknesses
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Details
7.7.2 Bio-Rad Laboratories Major Business
7.7.3 Bio-Rad Laboratories Inherited Metabolic Disorder Product and Services
7.7.4 Bio-Rad Laboratories Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Bio-Rad Laboratories Recent Developments/Updates
7.7.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
7.8 Novartis AG
7.8.1 Novartis AG Details
7.8.2 Novartis AG Major Business
7.8.3 Novartis AG Inherited Metabolic Disorder Product and Services
7.8.4 Novartis AG Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Novartis AG Recent Developments/Updates
7.8.6 Novartis AG Competitive Strengths & Weaknesses
7.9 AstaReal
7.9.1 AstaReal Details
7.9.2 AstaReal Major Business
7.9.3 AstaReal Inherited Metabolic Disorder Product and Services
7.9.4 AstaReal Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 AstaReal Recent Developments/Updates
7.9.6 AstaReal Competitive Strengths & Weaknesses
7.10 Regeneron Pharmaceuticals
7.10.1 Regeneron Pharmaceuticals Details
7.10.2 Regeneron Pharmaceuticals Major Business
7.10.3 Regeneron Pharmaceuticals Inherited Metabolic Disorder Product and Services
7.10.4 Regeneron Pharmaceuticals Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Regeneron Pharmaceuticals Recent Developments/Updates
7.10.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Biophytis
7.11.1 Biophytis Details
7.11.2 Biophytis Major Business
7.11.3 Biophytis Inherited Metabolic Disorder Product and Services
7.11.4 Biophytis Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Biophytis Recent Developments/Updates
7.11.6 Biophytis Competitive Strengths & Weaknesses
7.12 AbbVie
7.12.1 AbbVie Details
7.12.2 AbbVie Major Business
7.12.3 AbbVie Inherited Metabolic Disorder Product and Services
7.12.4 AbbVie Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 AbbVie Recent Developments/Updates
7.12.6 AbbVie Competitive Strengths & Weaknesses
7.13 Danone
7.13.1 Danone Details
7.13.2 Danone Major Business
7.13.3 Danone Inherited Metabolic Disorder Product and Services
7.13.4 Danone Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Danone Recent Developments/Updates
7.13.6 Danone Competitive Strengths & Weaknesses
7.14 Pfizer
7.14.1 Pfizer Details
7.14.2 Pfizer Major Business
7.14.3 Pfizer Inherited Metabolic Disorder Product and Services
7.14.4 Pfizer Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Pfizer Recent Developments/Updates
7.14.6 Pfizer Competitive Strengths & Weaknesses
7.15 Bristol Myers Squibb
7.15.1 Bristol Myers Squibb Details
7.15.2 Bristol Myers Squibb Major Business
7.15.3 Bristol Myers Squibb Inherited Metabolic Disorder Product and Services
7.15.4 Bristol Myers Squibb Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Bristol Myers Squibb Recent Developments/Updates
7.15.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.16 Biogen
7.16.1 Biogen Details
7.16.2 Biogen Major Business
7.16.3 Biogen Inherited Metabolic Disorder Product and Services
7.16.4 Biogen Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Biogen Recent Developments/Updates
7.16.6 Biogen Competitive Strengths & Weaknesses
7.17 GSK plc
7.17.1 GSK plc Details
7.17.2 GSK plc Major Business
7.17.3 GSK plc Inherited Metabolic Disorder Product and Services
7.17.4 GSK plc Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 GSK plc Recent Developments/Updates
7.17.6 GSK plc Competitive Strengths & Weaknesses
7.18 Roche Holding AG
7.18.1 Roche Holding AG Details
7.18.2 Roche Holding AG Major Business
7.18.3 Roche Holding AG Inherited Metabolic Disorder Product and Services
7.18.4 Roche Holding AG Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Roche Holding AG Recent Developments/Updates
7.18.6 Roche Holding AG Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Inherited Metabolic Disorder Industry Chain
8.2 Inherited Metabolic Disorder Upstream Analysis
8.3 Inherited Metabolic Disorder Midstream Analysis
8.4 Inherited Metabolic Disorder Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Inherited Metabolic Disorder Introduction
1.2 World Inherited Metabolic Disorder Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Inherited Metabolic Disorder Total Market by Region (by Headquarter Location)
1.3.1 World Inherited Metabolic Disorder Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Inherited Metabolic Disorder Market Size (2018-2029)
1.3.3 China Inherited Metabolic Disorder Market Size (2018-2029)
1.3.4 Europe Inherited Metabolic Disorder Market Size (2018-2029)
1.3.5 Japan Inherited Metabolic Disorder Market Size (2018-2029)
1.3.6 South Korea Inherited Metabolic Disorder Market Size (2018-2029)
1.3.7 ASEAN Inherited Metabolic Disorder Market Size (2018-2029)
1.3.8 India Inherited Metabolic Disorder Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Inherited Metabolic Disorder Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Inherited Metabolic Disorder Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Inherited Metabolic Disorder Consumption Value (2018-2029)
2.2 World Inherited Metabolic Disorder Consumption Value by Region
2.2.1 World Inherited Metabolic Disorder Consumption Value by Region (2018-2023)
2.2.2 World Inherited Metabolic Disorder Consumption Value Forecast by Region (2024-2029)
2.3 United States Inherited Metabolic Disorder Consumption Value (2018-2029)
2.4 China Inherited Metabolic Disorder Consumption Value (2018-2029)
2.5 Europe Inherited Metabolic Disorder Consumption Value (2018-2029)
2.6 Japan Inherited Metabolic Disorder Consumption Value (2018-2029)
2.7 South Korea Inherited Metabolic Disorder Consumption Value (2018-2029)
2.8 ASEAN Inherited Metabolic Disorder Consumption Value (2018-2029)
2.9 India Inherited Metabolic Disorder Consumption Value (2018-2029)
3 WORLD INHERITED METABOLIC DISORDER COMPANIES COMPETITIVE ANALYSIS
3.1 World Inherited Metabolic Disorder Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Inherited Metabolic Disorder Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Inherited Metabolic Disorder in 2022
3.2.3 Global Concentration Ratios (CR8) for Inherited Metabolic Disorder in 2022
3.3 Inherited Metabolic Disorder Company Evaluation Quadrant
3.4 Inherited Metabolic Disorder Market: Overall Company Footprint Analysis
3.4.1 Inherited Metabolic Disorder Market: Region Footprint
3.4.2 Inherited Metabolic Disorder Market: Company Product Type Footprint
3.4.3 Inherited Metabolic Disorder Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Inherited Metabolic Disorder Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Inherited Metabolic Disorder Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Inherited Metabolic Disorder Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Inherited Metabolic Disorder Consumption Value Comparison
4.2.1 United States VS China: Inherited Metabolic Disorder Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Inherited Metabolic Disorder Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Inherited Metabolic Disorder Companies and Market Share, 2018-2023
4.3.1 United States Based Inherited Metabolic Disorder Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Inherited Metabolic Disorder Revenue, (2018-2023)
4.4 China Based Companies Inherited Metabolic Disorder Revenue and Market Share, 2018-2023
4.4.1 China Based Inherited Metabolic Disorder Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Inherited Metabolic Disorder Revenue, (2018-2023)
4.5 Rest of World Based Inherited Metabolic Disorder Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Inherited Metabolic Disorder Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Inherited Metabolic Disorder Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Inherited Metabolic Disorder Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Enzyme Replacement Therapy
5.2.2 Cellular Transplantation
5.2.3 Small Molecule Based Therapy
5.2.4 Substrate Reduction Therapy
5.2.5 Gene Therapy
5.2.6 Drug Therapy
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World Inherited Metabolic Disorder Market Size by Type (2018-2023)
5.3.2 World Inherited Metabolic Disorder Market Size by Type (2024-2029)
5.3.3 World Inherited Metabolic Disorder Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Inherited Metabolic Disorder Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hurler Syndrome
6.2.2 Niemann-Pick Disease
6.2.3 Tay-Sachs Disease
6.2.4 Gaucher Disease
6.2.5 Gaucher Disease
6.2.6 Krabbe Disease
6.2.7 Others
6.3 Market Segment by Application
6.3.1 World Inherited Metabolic Disorder Market Size by Application (2018-2023)
6.3.2 World Inherited Metabolic Disorder Market Size by Application (2024-2029)
6.3.3 World Inherited Metabolic Disorder Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Mayo Clinic
7.1.1 Mayo Clinic Details
7.1.2 Mayo Clinic Major Business
7.1.3 Mayo Clinic Inherited Metabolic Disorder Product and Services
7.1.4 Mayo Clinic Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Mayo Clinic Recent Developments/Updates
7.1.6 Mayo Clinic Competitive Strengths & Weaknesses
7.2 Angeion Corporation
7.2.1 Angeion Corporation Details
7.2.2 Angeion Corporation Major Business
7.2.3 Angeion Corporation Inherited Metabolic Disorder Product and Services
7.2.4 Angeion Corporation Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Angeion Corporation Recent Developments/Updates
7.2.6 Angeion Corporation Competitive Strengths & Weaknesses
7.3 Abbott U.S.
7.3.1 Abbott U.S. Details
7.3.2 Abbott U.S. Major Business
7.3.3 Abbott U.S. Inherited Metabolic Disorder Product and Services
7.3.4 Abbott U.S. Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Abbott U.S. Recent Developments/Updates
7.3.6 Abbott U.S. Competitive Strengths & Weaknesses
7.4 Admera Health
7.4.1 Admera Health Details
7.4.2 Admera Health Major Business
7.4.3 Admera Health Inherited Metabolic Disorder Product and Services
7.4.4 Admera Health Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Admera Health Recent Developments/Updates
7.4.6 Admera Health Competitive Strengths & Weaknesses
7.5 Promega Corporation
7.5.1 Promega Corporation Details
7.5.2 Promega Corporation Major Business
7.5.3 Promega Corporation Inherited Metabolic Disorder Product and Services
7.5.4 Promega Corporation Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Promega Corporation Recent Developments/Updates
7.5.6 Promega Corporation Competitive Strengths & Weaknesses
7.6 Alomone Labs
7.6.1 Alomone Labs Details
7.6.2 Alomone Labs Major Business
7.6.3 Alomone Labs Inherited Metabolic Disorder Product and Services
7.6.4 Alomone Labs Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Alomone Labs Recent Developments/Updates
7.6.6 Alomone Labs Competitive Strengths & Weaknesses
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Details
7.7.2 Bio-Rad Laboratories Major Business
7.7.3 Bio-Rad Laboratories Inherited Metabolic Disorder Product and Services
7.7.4 Bio-Rad Laboratories Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Bio-Rad Laboratories Recent Developments/Updates
7.7.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
7.8 Novartis AG
7.8.1 Novartis AG Details
7.8.2 Novartis AG Major Business
7.8.3 Novartis AG Inherited Metabolic Disorder Product and Services
7.8.4 Novartis AG Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Novartis AG Recent Developments/Updates
7.8.6 Novartis AG Competitive Strengths & Weaknesses
7.9 AstaReal
7.9.1 AstaReal Details
7.9.2 AstaReal Major Business
7.9.3 AstaReal Inherited Metabolic Disorder Product and Services
7.9.4 AstaReal Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 AstaReal Recent Developments/Updates
7.9.6 AstaReal Competitive Strengths & Weaknesses
7.10 Regeneron Pharmaceuticals
7.10.1 Regeneron Pharmaceuticals Details
7.10.2 Regeneron Pharmaceuticals Major Business
7.10.3 Regeneron Pharmaceuticals Inherited Metabolic Disorder Product and Services
7.10.4 Regeneron Pharmaceuticals Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Regeneron Pharmaceuticals Recent Developments/Updates
7.10.6 Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
7.11 Biophytis
7.11.1 Biophytis Details
7.11.2 Biophytis Major Business
7.11.3 Biophytis Inherited Metabolic Disorder Product and Services
7.11.4 Biophytis Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Biophytis Recent Developments/Updates
7.11.6 Biophytis Competitive Strengths & Weaknesses
7.12 AbbVie
7.12.1 AbbVie Details
7.12.2 AbbVie Major Business
7.12.3 AbbVie Inherited Metabolic Disorder Product and Services
7.12.4 AbbVie Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 AbbVie Recent Developments/Updates
7.12.6 AbbVie Competitive Strengths & Weaknesses
7.13 Danone
7.13.1 Danone Details
7.13.2 Danone Major Business
7.13.3 Danone Inherited Metabolic Disorder Product and Services
7.13.4 Danone Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Danone Recent Developments/Updates
7.13.6 Danone Competitive Strengths & Weaknesses
7.14 Pfizer
7.14.1 Pfizer Details
7.14.2 Pfizer Major Business
7.14.3 Pfizer Inherited Metabolic Disorder Product and Services
7.14.4 Pfizer Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Pfizer Recent Developments/Updates
7.14.6 Pfizer Competitive Strengths & Weaknesses
7.15 Bristol Myers Squibb
7.15.1 Bristol Myers Squibb Details
7.15.2 Bristol Myers Squibb Major Business
7.15.3 Bristol Myers Squibb Inherited Metabolic Disorder Product and Services
7.15.4 Bristol Myers Squibb Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Bristol Myers Squibb Recent Developments/Updates
7.15.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
7.16 Biogen
7.16.1 Biogen Details
7.16.2 Biogen Major Business
7.16.3 Biogen Inherited Metabolic Disorder Product and Services
7.16.4 Biogen Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Biogen Recent Developments/Updates
7.16.6 Biogen Competitive Strengths & Weaknesses
7.17 GSK plc
7.17.1 GSK plc Details
7.17.2 GSK plc Major Business
7.17.3 GSK plc Inherited Metabolic Disorder Product and Services
7.17.4 GSK plc Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 GSK plc Recent Developments/Updates
7.17.6 GSK plc Competitive Strengths & Weaknesses
7.18 Roche Holding AG
7.18.1 Roche Holding AG Details
7.18.2 Roche Holding AG Major Business
7.18.3 Roche Holding AG Inherited Metabolic Disorder Product and Services
7.18.4 Roche Holding AG Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Roche Holding AG Recent Developments/Updates
7.18.6 Roche Holding AG Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Inherited Metabolic Disorder Industry Chain
8.2 Inherited Metabolic Disorder Upstream Analysis
8.3 Inherited Metabolic Disorder Midstream Analysis
8.4 Inherited Metabolic Disorder Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Inherited Metabolic Disorder Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Inherited Metabolic Disorder Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Inherited Metabolic Disorder Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Inherited Metabolic Disorder Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Inherited Metabolic Disorder Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Inherited Metabolic Disorder Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Inherited Metabolic Disorder Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Inherited Metabolic Disorder Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Inherited Metabolic Disorder Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Inherited Metabolic Disorder Players in 2022
Table 12. World Inherited Metabolic Disorder Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Inherited Metabolic Disorder Company Evaluation Quadrant
Table 14. Head Office of Key Inherited Metabolic Disorder Player
Table 15. Inherited Metabolic Disorder Market: Company Product Type Footprint
Table 16. Inherited Metabolic Disorder Market: Company Product Application Footprint
Table 17. Inherited Metabolic Disorder Mergers & Acquisitions Activity
Table 18. United States VS China Inherited Metabolic Disorder Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Inherited Metabolic Disorder Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Inherited Metabolic Disorder Companies, Headquarters (States, Country)
Table 21. United States Based Companies Inherited Metabolic Disorder Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Inherited Metabolic Disorder Revenue Market Share (2018-2023)
Table 23. China Based Inherited Metabolic Disorder Companies, Headquarters (Province, Country)
Table 24. China Based Companies Inherited Metabolic Disorder Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Inherited Metabolic Disorder Revenue Market Share (2018-2023)
Table 26. Rest of World Based Inherited Metabolic Disorder Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Inherited Metabolic Disorder Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Inherited Metabolic Disorder Revenue Market Share (2018-2023)
Table 29. World Inherited Metabolic Disorder Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Inherited Metabolic Disorder Market Size by Type (2018-2023) & (USD Million)
Table 31. World Inherited Metabolic Disorder Market Size by Type (2024-2029) & (USD Million)
Table 32. World Inherited Metabolic Disorder Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Inherited Metabolic Disorder Market Size by Application (2018-2023) & (USD Million)
Table 34. World Inherited Metabolic Disorder Market Size by Application (2024-2029) & (USD Million)
Table 35. Mayo Clinic Basic Information, Area Served and Competitors
Table 36. Mayo Clinic Major Business
Table 37. Mayo Clinic Inherited Metabolic Disorder Product and Services
Table 38. Mayo Clinic Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Mayo Clinic Recent Developments/Updates
Table 40. Mayo Clinic Competitive Strengths & Weaknesses
Table 41. Angeion Corporation Basic Information, Area Served and Competitors
Table 42. Angeion Corporation Major Business
Table 43. Angeion Corporation Inherited Metabolic Disorder Product and Services
Table 44. Angeion Corporation Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Angeion Corporation Recent Developments/Updates
Table 46. Angeion Corporation Competitive Strengths & Weaknesses
Table 47. Abbott U.S. Basic Information, Area Served and Competitors
Table 48. Abbott U.S. Major Business
Table 49. Abbott U.S. Inherited Metabolic Disorder Product and Services
Table 50. Abbott U.S. Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Abbott U.S. Recent Developments/Updates
Table 52. Abbott U.S. Competitive Strengths & Weaknesses
Table 53. Admera Health Basic Information, Area Served and Competitors
Table 54. Admera Health Major Business
Table 55. Admera Health Inherited Metabolic Disorder Product and Services
Table 56. Admera Health Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Admera Health Recent Developments/Updates
Table 58. Admera Health Competitive Strengths & Weaknesses
Table 59. Promega Corporation Basic Information, Area Served and Competitors
Table 60. Promega Corporation Major Business
Table 61. Promega Corporation Inherited Metabolic Disorder Product and Services
Table 62. Promega Corporation Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Promega Corporation Recent Developments/Updates
Table 64. Promega Corporation Competitive Strengths & Weaknesses
Table 65. Alomone Labs Basic Information, Area Served and Competitors
Table 66. Alomone Labs Major Business
Table 67. Alomone Labs Inherited Metabolic Disorder Product and Services
Table 68. Alomone Labs Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Alomone Labs Recent Developments/Updates
Table 70. Alomone Labs Competitive Strengths & Weaknesses
Table 71. Bio-Rad Laboratories Basic Information, Area Served and Competitors
Table 72. Bio-Rad Laboratories Major Business
Table 73. Bio-Rad Laboratories Inherited Metabolic Disorder Product and Services
Table 74. Bio-Rad Laboratories Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Bio-Rad Laboratories Recent Developments/Updates
Table 76. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 77. Novartis AG Basic Information, Area Served and Competitors
Table 78. Novartis AG Major Business
Table 79. Novartis AG Inherited Metabolic Disorder Product and Services
Table 80. Novartis AG Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Novartis AG Recent Developments/Updates
Table 82. Novartis AG Competitive Strengths & Weaknesses
Table 83. AstaReal Basic Information, Area Served and Competitors
Table 84. AstaReal Major Business
Table 85. AstaReal Inherited Metabolic Disorder Product and Services
Table 86. AstaReal Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. AstaReal Recent Developments/Updates
Table 88. AstaReal Competitive Strengths & Weaknesses
Table 89. Regeneron Pharmaceuticals Basic Information, Area Served and Competitors
Table 90. Regeneron Pharmaceuticals Major Business
Table 91. Regeneron Pharmaceuticals Inherited Metabolic Disorder Product and Services
Table 92. Regeneron Pharmaceuticals Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Regeneron Pharmaceuticals Recent Developments/Updates
Table 94. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
Table 95. Biophytis Basic Information, Area Served and Competitors
Table 96. Biophytis Major Business
Table 97. Biophytis Inherited Metabolic Disorder Product and Services
Table 98. Biophytis Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Biophytis Recent Developments/Updates
Table 100. Biophytis Competitive Strengths & Weaknesses
Table 101. AbbVie Basic Information, Area Served and Competitors
Table 102. AbbVie Major Business
Table 103. AbbVie Inherited Metabolic Disorder Product and Services
Table 104. AbbVie Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. AbbVie Recent Developments/Updates
Table 106. AbbVie Competitive Strengths & Weaknesses
Table 107. Danone Basic Information, Area Served and Competitors
Table 108. Danone Major Business
Table 109. Danone Inherited Metabolic Disorder Product and Services
Table 110. Danone Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Danone Recent Developments/Updates
Table 112. Danone Competitive Strengths & Weaknesses
Table 113. Pfizer Basic Information, Area Served and Competitors
Table 114. Pfizer Major Business
Table 115. Pfizer Inherited Metabolic Disorder Product and Services
Table 116. Pfizer Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Pfizer Recent Developments/Updates
Table 118. Pfizer Competitive Strengths & Weaknesses
Table 119. Bristol Myers Squibb Basic Information, Area Served and Competitors
Table 120. Bristol Myers Squibb Major Business
Table 121. Bristol Myers Squibb Inherited Metabolic Disorder Product and Services
Table 122. Bristol Myers Squibb Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Bristol Myers Squibb Recent Developments/Updates
Table 124. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 125. Biogen Basic Information, Area Served and Competitors
Table 126. Biogen Major Business
Table 127. Biogen Inherited Metabolic Disorder Product and Services
Table 128. Biogen Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Biogen Recent Developments/Updates
Table 130. Biogen Competitive Strengths & Weaknesses
Table 131. GSK plc Basic Information, Area Served and Competitors
Table 132. GSK plc Major Business
Table 133. GSK plc Inherited Metabolic Disorder Product and Services
Table 134. GSK plc Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. GSK plc Recent Developments/Updates
Table 136. Roche Holding AG Basic Information, Area Served and Competitors
Table 137. Roche Holding AG Major Business
Table 138. Roche Holding AG Inherited Metabolic Disorder Product and Services
Table 139. Roche Holding AG Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Inherited Metabolic Disorder Upstream (Raw Materials)
Table 141. Inherited Metabolic Disorder Typical Customers
Table 1. World Inherited Metabolic Disorder Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Inherited Metabolic Disorder Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Inherited Metabolic Disorder Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Inherited Metabolic Disorder Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Inherited Metabolic Disorder Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Inherited Metabolic Disorder Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Inherited Metabolic Disorder Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Inherited Metabolic Disorder Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Inherited Metabolic Disorder Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Inherited Metabolic Disorder Players in 2022
Table 12. World Inherited Metabolic Disorder Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Inherited Metabolic Disorder Company Evaluation Quadrant
Table 14. Head Office of Key Inherited Metabolic Disorder Player
Table 15. Inherited Metabolic Disorder Market: Company Product Type Footprint
Table 16. Inherited Metabolic Disorder Market: Company Product Application Footprint
Table 17. Inherited Metabolic Disorder Mergers & Acquisitions Activity
Table 18. United States VS China Inherited Metabolic Disorder Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Inherited Metabolic Disorder Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Inherited Metabolic Disorder Companies, Headquarters (States, Country)
Table 21. United States Based Companies Inherited Metabolic Disorder Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Inherited Metabolic Disorder Revenue Market Share (2018-2023)
Table 23. China Based Inherited Metabolic Disorder Companies, Headquarters (Province, Country)
Table 24. China Based Companies Inherited Metabolic Disorder Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Inherited Metabolic Disorder Revenue Market Share (2018-2023)
Table 26. Rest of World Based Inherited Metabolic Disorder Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Inherited Metabolic Disorder Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Inherited Metabolic Disorder Revenue Market Share (2018-2023)
Table 29. World Inherited Metabolic Disorder Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Inherited Metabolic Disorder Market Size by Type (2018-2023) & (USD Million)
Table 31. World Inherited Metabolic Disorder Market Size by Type (2024-2029) & (USD Million)
Table 32. World Inherited Metabolic Disorder Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Inherited Metabolic Disorder Market Size by Application (2018-2023) & (USD Million)
Table 34. World Inherited Metabolic Disorder Market Size by Application (2024-2029) & (USD Million)
Table 35. Mayo Clinic Basic Information, Area Served and Competitors
Table 36. Mayo Clinic Major Business
Table 37. Mayo Clinic Inherited Metabolic Disorder Product and Services
Table 38. Mayo Clinic Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Mayo Clinic Recent Developments/Updates
Table 40. Mayo Clinic Competitive Strengths & Weaknesses
Table 41. Angeion Corporation Basic Information, Area Served and Competitors
Table 42. Angeion Corporation Major Business
Table 43. Angeion Corporation Inherited Metabolic Disorder Product and Services
Table 44. Angeion Corporation Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Angeion Corporation Recent Developments/Updates
Table 46. Angeion Corporation Competitive Strengths & Weaknesses
Table 47. Abbott U.S. Basic Information, Area Served and Competitors
Table 48. Abbott U.S. Major Business
Table 49. Abbott U.S. Inherited Metabolic Disorder Product and Services
Table 50. Abbott U.S. Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Abbott U.S. Recent Developments/Updates
Table 52. Abbott U.S. Competitive Strengths & Weaknesses
Table 53. Admera Health Basic Information, Area Served and Competitors
Table 54. Admera Health Major Business
Table 55. Admera Health Inherited Metabolic Disorder Product and Services
Table 56. Admera Health Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Admera Health Recent Developments/Updates
Table 58. Admera Health Competitive Strengths & Weaknesses
Table 59. Promega Corporation Basic Information, Area Served and Competitors
Table 60. Promega Corporation Major Business
Table 61. Promega Corporation Inherited Metabolic Disorder Product and Services
Table 62. Promega Corporation Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Promega Corporation Recent Developments/Updates
Table 64. Promega Corporation Competitive Strengths & Weaknesses
Table 65. Alomone Labs Basic Information, Area Served and Competitors
Table 66. Alomone Labs Major Business
Table 67. Alomone Labs Inherited Metabolic Disorder Product and Services
Table 68. Alomone Labs Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Alomone Labs Recent Developments/Updates
Table 70. Alomone Labs Competitive Strengths & Weaknesses
Table 71. Bio-Rad Laboratories Basic Information, Area Served and Competitors
Table 72. Bio-Rad Laboratories Major Business
Table 73. Bio-Rad Laboratories Inherited Metabolic Disorder Product and Services
Table 74. Bio-Rad Laboratories Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Bio-Rad Laboratories Recent Developments/Updates
Table 76. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 77. Novartis AG Basic Information, Area Served and Competitors
Table 78. Novartis AG Major Business
Table 79. Novartis AG Inherited Metabolic Disorder Product and Services
Table 80. Novartis AG Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Novartis AG Recent Developments/Updates
Table 82. Novartis AG Competitive Strengths & Weaknesses
Table 83. AstaReal Basic Information, Area Served and Competitors
Table 84. AstaReal Major Business
Table 85. AstaReal Inherited Metabolic Disorder Product and Services
Table 86. AstaReal Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. AstaReal Recent Developments/Updates
Table 88. AstaReal Competitive Strengths & Weaknesses
Table 89. Regeneron Pharmaceuticals Basic Information, Area Served and Competitors
Table 90. Regeneron Pharmaceuticals Major Business
Table 91. Regeneron Pharmaceuticals Inherited Metabolic Disorder Product and Services
Table 92. Regeneron Pharmaceuticals Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Regeneron Pharmaceuticals Recent Developments/Updates
Table 94. Regeneron Pharmaceuticals Competitive Strengths & Weaknesses
Table 95. Biophytis Basic Information, Area Served and Competitors
Table 96. Biophytis Major Business
Table 97. Biophytis Inherited Metabolic Disorder Product and Services
Table 98. Biophytis Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Biophytis Recent Developments/Updates
Table 100. Biophytis Competitive Strengths & Weaknesses
Table 101. AbbVie Basic Information, Area Served and Competitors
Table 102. AbbVie Major Business
Table 103. AbbVie Inherited Metabolic Disorder Product and Services
Table 104. AbbVie Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. AbbVie Recent Developments/Updates
Table 106. AbbVie Competitive Strengths & Weaknesses
Table 107. Danone Basic Information, Area Served and Competitors
Table 108. Danone Major Business
Table 109. Danone Inherited Metabolic Disorder Product and Services
Table 110. Danone Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Danone Recent Developments/Updates
Table 112. Danone Competitive Strengths & Weaknesses
Table 113. Pfizer Basic Information, Area Served and Competitors
Table 114. Pfizer Major Business
Table 115. Pfizer Inherited Metabolic Disorder Product and Services
Table 116. Pfizer Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Pfizer Recent Developments/Updates
Table 118. Pfizer Competitive Strengths & Weaknesses
Table 119. Bristol Myers Squibb Basic Information, Area Served and Competitors
Table 120. Bristol Myers Squibb Major Business
Table 121. Bristol Myers Squibb Inherited Metabolic Disorder Product and Services
Table 122. Bristol Myers Squibb Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Bristol Myers Squibb Recent Developments/Updates
Table 124. Bristol Myers Squibb Competitive Strengths & Weaknesses
Table 125. Biogen Basic Information, Area Served and Competitors
Table 126. Biogen Major Business
Table 127. Biogen Inherited Metabolic Disorder Product and Services
Table 128. Biogen Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Biogen Recent Developments/Updates
Table 130. Biogen Competitive Strengths & Weaknesses
Table 131. GSK plc Basic Information, Area Served and Competitors
Table 132. GSK plc Major Business
Table 133. GSK plc Inherited Metabolic Disorder Product and Services
Table 134. GSK plc Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. GSK plc Recent Developments/Updates
Table 136. Roche Holding AG Basic Information, Area Served and Competitors
Table 137. Roche Holding AG Major Business
Table 138. Roche Holding AG Inherited Metabolic Disorder Product and Services
Table 139. Roche Holding AG Inherited Metabolic Disorder Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Inherited Metabolic Disorder Upstream (Raw Materials)
Table 141. Inherited Metabolic Disorder Typical Customers
LIST OF FIGURES
Figure 1. Inherited Metabolic Disorder Picture
Figure 2. World Inherited Metabolic Disorder Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Inherited Metabolic Disorder Total Market Size (2018-2029) & (USD Million)
Figure 4. World Inherited Metabolic Disorder Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Inherited Metabolic Disorder Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Inherited Metabolic Disorder Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Inherited Metabolic Disorder Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Inherited Metabolic Disorder Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Inherited Metabolic Disorder Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Inherited Metabolic Disorder Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Inherited Metabolic Disorder Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Inherited Metabolic Disorder Revenue (2018-2029) & (USD Million)
Figure 13. Inherited Metabolic Disorder Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 16. World Inherited Metabolic Disorder Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 18. China Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 23. India Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Inherited Metabolic Disorder by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Inherited Metabolic Disorder Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Inherited Metabolic Disorder Markets in 2022
Figure 27. United States VS China: Inherited Metabolic Disorder Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Inherited Metabolic Disorder Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Inherited Metabolic Disorder Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Inherited Metabolic Disorder Market Size Market Share by Type in 2022
Figure 31. Enzyme Replacement Therapy
Figure 32. Cellular Transplantation
Figure 33. Small Molecule Based Therapy
Figure 34. Substrate Reduction Therapy
Figure 35. Gene Therapy
Figure 36. Drug Therapy
Figure 37. Others
Figure 38. World Inherited Metabolic Disorder Market Size Market Share by Type (2018-2029)
Figure 39. World Inherited Metabolic Disorder Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Inherited Metabolic Disorder Market Size Market Share by Application in 2022
Figure 41. Hurler Syndrome
Figure 42. Niemann-Pick Disease
Figure 43. Tay-Sachs Disease
Figure 44. Gaucher Disease
Figure 45. Fabry Disease
Figure 46. Krabbe Disease
Figure 47. Others
Figure 48. Inherited Metabolic Disorder Industrial Chain
Figure 49. Methodology
Figure 50. Research Process and Data Source
Figure 1. Inherited Metabolic Disorder Picture
Figure 2. World Inherited Metabolic Disorder Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Inherited Metabolic Disorder Total Market Size (2018-2029) & (USD Million)
Figure 4. World Inherited Metabolic Disorder Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Inherited Metabolic Disorder Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Inherited Metabolic Disorder Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Inherited Metabolic Disorder Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Inherited Metabolic Disorder Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Inherited Metabolic Disorder Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Inherited Metabolic Disorder Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Inherited Metabolic Disorder Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Inherited Metabolic Disorder Revenue (2018-2029) & (USD Million)
Figure 13. Inherited Metabolic Disorder Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 16. World Inherited Metabolic Disorder Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 18. China Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 23. India Inherited Metabolic Disorder Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Inherited Metabolic Disorder by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Inherited Metabolic Disorder Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Inherited Metabolic Disorder Markets in 2022
Figure 27. United States VS China: Inherited Metabolic Disorder Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Inherited Metabolic Disorder Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Inherited Metabolic Disorder Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Inherited Metabolic Disorder Market Size Market Share by Type in 2022
Figure 31. Enzyme Replacement Therapy
Figure 32. Cellular Transplantation
Figure 33. Small Molecule Based Therapy
Figure 34. Substrate Reduction Therapy
Figure 35. Gene Therapy
Figure 36. Drug Therapy
Figure 37. Others
Figure 38. World Inherited Metabolic Disorder Market Size Market Share by Type (2018-2029)
Figure 39. World Inherited Metabolic Disorder Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Inherited Metabolic Disorder Market Size Market Share by Application in 2022
Figure 41. Hurler Syndrome
Figure 42. Niemann-Pick Disease
Figure 43. Tay-Sachs Disease
Figure 44. Gaucher Disease
Figure 45. Fabry Disease
Figure 46. Krabbe Disease
Figure 47. Others
Figure 48. Inherited Metabolic Disorder Industrial Chain
Figure 49. Methodology
Figure 50. Research Process and Data Source
